Combined lanreotide autogel and temozolomide in progressive neuroendocrine tumours: an interim safety analysis of the SONNET study - Hoersch, D.; Raderer, M.; Lahner, H.; Rinke, A.; Denecke, T.; Koch, A.; Raspel, A.; Naschold, B.; Houchard, A.; Pavel, Marianne Ellen (2017)
EVALuna2:34127